Search hospitals > Hawaii > Honolulu
East-West Medical Research Institute
Claim this profileHonolulu, Hawaii 96814
Global Leader in Diabetes
Global Leader in Type 2 Diabetes
Conducts research for Obesity
Conducts research for COVID-19
Conducts research for Coronavirus
121 reported clinical trials
2 medical researchers
Summary
East-West Medical Research Institute is a medical facility located in Honolulu, Hawaii. This center is recognized for care of Diabetes, Type 2 Diabetes, Obesity, COVID-19, Coronavirus and other specialties. East-West Medical Research Institute is involved with conducting 121 clinical trials across 68 conditions. There are 2 research doctors associated with this hospital, such as Cindy H. T. Pau and David Fitz-Patrick.Top PIs
Cindy H. T. PauEast-West Medical Research Institute1 year of reported clinical research
Studies Obesity
Studies Diabetes
6 reported clinical trials
7 drugs studied
David Fitz-PatrickEast-West Medical Research Institute4 years of reported clinical research
Studies Lassa Fever
Studies Type 2 Diabetes
2 reported clinical trials
3 drugs studied
Clinical Trials running at East-West Medical Research Institute
Obesity
Obstructive Sleep Apnea
Shingles
Flu
Non-alcoholic Fatty Liver Disease
Type 2 Diabetes
Liver Disease
Fatty Liver Disease
Human
Diabetes
CagriSema vs. Tirzepatide
for Weight Loss in Obesity
This study will look at how well CagriSema compared to Tirzepatide helps people lower their body weight. CagriSema is a new investigational medicine developed by Novo Nordisk that combines Cagrilintide and Semaglutide. CagriSema is not yet being prescribed by doctors. Participant will get injections once a week throughout the treatment period. Participant will inject the study medicine under the skin with a pen injector in the thigh, stomach, or upper arm. After a first low dose, the study medicine will be gradually increased until reaching the planned dose (2.4 mg CagriSema or 15 mg Tirzepatide). The study will last for about one and a half year for each participant.
Recruiting2 awards Phase 33 criteria
Retatrutide
for Type 2 Diabetes and Obesity
The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants who have obesity or overweight (J1I-MC-GZBK master protocol) including a subset of participants who have obstructive sleep apnea (OSA) (J1I-MC-GSA2). The study will last about 89 weeks and will include up to 24 visits.
Recruiting1 award Phase 37 criteria
Retatrutide
for Obesity
The purpose of this study is to evaluate the efficacy and safety of retatrutide in participants who have obesity or overweight (J1I-MC-GZBJ master protocol) including subsets of participants who have knee osteoarthritis (OA) (J1I-MC-GOA1) or who have obstructive sleep apnea (OSA) (J1I-MC-GSA1). This study will last about 89 weeks and will include up to 24 visits.
Recruiting1 award Phase 39 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at East-West Medical Research Institute?
East-West Medical Research Institute is a medical facility located in Honolulu, Hawaii. This center is recognized for care of Diabetes, Type 2 Diabetes, Obesity, COVID-19, Coronavirus and other specialties. East-West Medical Research Institute is involved with conducting 121 clinical trials across 68 conditions. There are 2 research doctors associated with this hospital, such as Cindy H. T. Pau and David Fitz-Patrick.